Thi-DPPY
Modify Date: 2024-09-29 21:00:44
Thi-DPPY structure
|
Common Name | Thi-DPPY | ||
|---|---|---|---|---|
| CAS Number | 2307699-34-7 | Molecular Weight | 566.07 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C28H28ClN5O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Thi-DPPYThi-DPPY (compound 8e) is a potent and orally active JAK3 inhibitor with IC50 values of 62.4, 1.38 nM for BTK, JAK, respectively. Thi-DPPY shows anti-proliferative activity against HBE cells. Thi-DPPY shows anti-inflammatory activity in vivo. Thi-DPPY has the potential for the research of idiopathic pulmonary fibrosis (IPF)[1]. |
| Name | Thi-DPPY |
|---|
| Description | Thi-DPPY (compound 8e) is a potent and orally active JAK3 inhibitor with IC50 values of 62.4, 1.38 nM for BTK, JAK, respectively. Thi-DPPY shows anti-proliferative activity against HBE cells. Thi-DPPY shows anti-inflammatory activity in vivo. Thi-DPPY has the potential for the research of idiopathic pulmonary fibrosis (IPF)[1]. |
|---|---|
| Related Catalog | |
| Target |
JAK3:1.38 nM (IC50) BTK:62.4 nM (IC50) |
| In Vitro | DPPY (compound 8e) shows anti-proliferative activity against HBE (human bronchial epithelia) cells with an IC50 of 39.0 µM[1]. |
| In Vivo | DPPY (30, 60 mg/kg; i.g., once daily for 14 days) shows anti-IPF agents on the lung morphology and lung coefficient in mouse model[1]. DPPY (30, 60 mg/kg) significantly decreases the expression of IL-6, IL-17A, TNF-α and MDA in lung tissue in a dose dependent manner[1]. Animal Model: 5-6 week old, 20-25 g, C57BL mice (BLM-induced pulmonary inflammation and pulmonary fibrosis model)[1] Dosage: 30, 60 mg/kg Administration: I.g.; once daily for 14 days Result: Attenuated the pulmonary morphology changes and reduced the collagen disposition induced by BLM in mouse lung. |
| References |
| Molecular Formula | C28H28ClN5O4S |
|---|---|
| Molecular Weight | 566.07 |